Illinois providers oppose 340B changes as PhRMA calls for reform
Six Illinois hospital and health system CEOs signed a letter opposing changes to a federal drug discount program, but pharmaceutical companies continue to call for reforms.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
